Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,370 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
miR-497 inhibited proliferation, migration and invasion of thyroid papillary carcinoma cells by negatively regulating YAP1 expression.
Cheng H, Dong H, Feng J, Tian H, Zhang H, Xu L. Cheng H, et al. Among authors: dong h. Onco Targets Ther. 2018 Aug 10;11:4711-4721. doi: 10.2147/OTT.S164052. eCollection 2018. Onco Targets Ther. 2018. Retraction in: Onco Targets Ther. 2023 Jan 19;16:47-48. doi: 10.2147/OTT.S405151 PMID: 30127619 Free PMC article. Retracted.
Phase 2 pilot trial of tislelizumab plus low-dose nab-paclitaxel for extensive very high-risk non-muscle-invasive bladder cancer.
Qie Y, Huang S, Shen C, Wu Z, Da L, Jia K, Zhang Z, Zhao G, Wang L, Xu G, Zhao Y, Liang R, Guo J, Li C, Dong H, Li M, Li H, Chen H, Tian D, Wu C, Zhang W, An Z, Wang H, Niu Y, Hu H. Qie Y, et al. Among authors: dong h. Clin Cancer Res. 2025 Jan 7. doi: 10.1158/1078-0432.CCR-24-3321. Online ahead of print. Clin Cancer Res. 2025. PMID: 39777450
11,370 results
You have reached the last available page of results. Please see the User Guide for more information.